Showing posts with label Science. Show all posts
Showing posts with label Science. Show all posts

21 December 2010

The moon is made of cheddar cheese?

The moon was orange last night... As many of you know, there was a total lunar eclipse last night. Lunar eclipses are rarely visible in the northeast US sky, and this would be a never-repeated-in-my-lifetime event. The reason that we could see this eclipse in Maryland is that the sun is at its most southern point on the winter solstice (December 21). The sun has to be opposite the moon for a total eclipse to occur, and the full moon this month is high in the northern sky.

For a science geek, this was an opportunity not to be missed. And it was a clear night.

The eclipse was maximal at 2:41 am EST, so I set my alarm for 2:30. I could see the moon out of my bedroom window, though it took some contorting. It wasn't like a solar eclipse, where there is a black shadow obscuring the sun, but the moon was definitely darker, like a shadow was obscuring it. TheHusband and I got dressed and trudged outside to take pictures (and see it without kneeling and twisting about to see it out the window). I tried to wake ThePinkThing, but she grumbled, rolled over, and pulled the cover over her head. Her loss, and she's grumpy about it this morning.

At 3:17 am, the moon's color was the most orangey-red. Really lovely and obvious to the naked eye, even without binoculars (TH's binocs are 30 years old and show their age). We have a high-level point-and-shoot camera with lots of settings but no tripod. We were able to get some really nice shots anyway on the "Nightime Nature" setting.








Now I want to see a total solar eclipse, someday. And the Aurora Borealis. Don't you?

28 September 2010

Helpful pie-charting

So, as I said in my last post, one of the things I do for a living is read (and evaluate) clinical trials. Much of the math and statistics remains beyond the ability of my pea-sized math brain to understand. But I do often catch it when the authors are trying to pull a fast one on me. And that irks me.


Dear Scientist,


If you insist on including graphs as scientifically "meaningful" as the one below in your really, really important medical study, you will be laughed at. Then I will wield Janiece's Shovel of Doom (TM) and make you go away.




xoxoxo,
Neurondoc

24 September 2010

Thank God for Biostatisticians!

I work in the medical field. That's a big "Duh!", I know. Part of my job as a physician is to keep up-to-date in my field (neurology). Most of the meaningful neurology articles published in reputable journals come in the form of clinical studies. And those clinical studies, whether prospective randomized placebo-controlled trials or retrospective observational case series studies, include statistics.

I hate statistics. Really, I do. Why, you ask? Well, that's because my stats course in medical school consisted of lectures from a biostats grad student on 8 or 10 successive Friday afternoons. This grad student did not want to be there, and neither did we. It was poorly taught, and (certainly in my case) poorly learned. I swear that I came out of med school with only one statistics "fact" in my head -- p values should be greater than 0.05 (P> .05) for the study results to be significant. Let's just say that this minimalistic view of biostatistics was not really adequate for a practicing physician.

I'm not here to teach or explain statistics (God, no!), but I have learned quite a bit more useful methods of evaluating the adequacy of statistical analyses over the past few years. I greatly appreciate the biostatisticians in my (professional) life (thank you! thank you!).

And so I present this video for your viewing pleasure (found on youtube, of course). If you aren't interested in statistics or scientific analyses, then feel free to move along. But it had me laughing out loud.

21 October 2009

What She Said

You know, I really can't add a thing to this article. I only wish that the morons of the world (ahem, Jenny McCarthy) would read it with an open mind and actually learn something. But then again, pigs'd fly first. Instead, credulous people choose to believe in crackpot theories and revile people who work hard to reduce sickness in the world. Oh, and make death threats against them. Why oh why, do people actually listen to Jenny instead of Amy?

Truly -- while people believe that they are exercising their rights to make their own medical decisions and appropriate medical decisions for their children, inadequate immunization brings a great deal of risk to the population as a whole, as well as to each individual person. Herd immunity is a function of a large enough percent of the population being vaccinated -- if that number too low, herd immunity disappears. You need quite a high percentage of population vaccinated to provide herd immunity for the community. For example, measles and pertussis are rather contagious and may require up to 94% of the population to be vaccinated for that vaccine to confer herd immunity.

Herd immunity confers protection to those who either can't receive a vaccine due to health reasons (immunocompromised, cancer, chemotherapy, infants) or people whose vaccines have failed (they don't "take" in everyone). Therefore, when these "concerned parents" choose not to vaccinate their children, they are actually endangering the health of other parents' kids, even if those kids are vaccinated. So while part of me says "fuck you, evil parents who don't vaccinate their kids, your kids'll pay for it", in reality, it is those who are sick and vulnerable that bear the brunt of these people's folly.

19 August 2009

So, would you rather...

...catch swine flu or become a zombie?

I am not sure of the answer, but a bunch of mathematicians at University of Ottawa (those wacky Canucks!) used mathematical models to calculate the effects of plausible pandemics by using an infestation of zombies as the disease vector. This paper has been published.

For disease models, the researchers picked the typical slow-movie zombies from movies such as Night of the Living Dead which infect humans with a bite and can only be killed by a blow to the head. The population was broken down into live humans, zombies and dead zombies. In their model, there was no cure other than complete eradication, and that had to happen right from the start with coordination of efforts. "A zombie outbreak is likely to lead to the collapse of civilisation, unless it is dealt with quickly," they write in the paper. "Modelling zombies would be the same as modelling swine flu, with some differences for sure, but it is much more interesting to read."

For some odd reason, this talk of the end of civilization reminds of a long thread on the Bujold listserv, from at least 10 years ago. Someone postulated that if all of the members of the listserv were magically transported to an uninhabited planet with no Earth food, water, medical equipment or tools, we would all eventually die. The planet did potentially have edible items and potable water but how would we tell? In this exercise, an evil (or mischievous) alien named Yeltar was the reason behind our removal from Earth. After much discussion, it was pretty well agreed upon that, given the above scenario, the colony on Bujoldia was doomed. If the planet came with a user's manual and was eminently hospitable, then perhaps we'd scratch by. Perhaps. And occasionally I still think "Bite me, Yeltar"...
_________________
H/T to The Telegraph
Photo: Tyler Hicks/The New York Times

29 July 2009

Beware the Spinal Trap

In April 2008, Simon Singh wrote a piece for the Guardian that was critical of chiropractic "treatments". His assertion was that chiropractic treatment is not supported by evidence. The British Chiropractic Association (BCA) responded to this article by suing sued Mr Singh personally for libel. They initially refused to publish a rebuttal to his criticism, or to provide any evidence supporting the effectiveness of their treatments. Eventually the BCA produced a list of studies which supposedly supported chiropractic treatments, but all of them were problematic. Steven Novella at Science Based Medicine discussed these studies at length here. Unfortunately, in England the burden of proof in a libel suit is on the accused party (i.e., guilty until proven innnocent) and the judgment in the initial trial was that Mr Sungh was guilty of libel, based on a narrow definition of the word bogus.

Bloggers are being urged to repost an edited version of the article that got Simon Singh in trouble today. I found a copy of the original article but I am posting the edited version mostly to protect myself, just in case.

Beware the spinal trap
Some practitioners claim it is a cure-all, but the research suggests chiropractic therapy has mixed results – and can even be lethal, says Simon Singh.

You might be surprised to know that the founder of chiropractic therapy, Daniel David Palmer, wrote that “99% of all diseases are caused by displaced vertebrae”. In the 1860s, Palmer began to develop his theory that the spine was involved in almost every illness because the spinal cord connects the brain to the rest of the body. Therefore any misalignment could cause a problem in distant parts of the body.

In fact, Palmer’s first chiropractic intervention supposedly cured a man who had been profoundly deaf for 17 years. His second treatment was equally strange, because he claimed that he treated a patient with heart trouble by correcting a displaced vertebra.

You might think that modern chiropractors restrict themselves to treating back problems, but in fact some still possess quite wacky ideas. The fundamentalists argue that they can cure anything, including helping treat children with colic, sleeping and feeding problems, frequent ear infections, asthma and prolonged crying – even though there is not a jot of evidence.

I can confidently label these assertions as utter nonsense because I have co-authored a book about alternative medicine with the world’s first professor of complementary medicine, Edzard Ernst. He learned chiropractic techniques himself and used them as a doctor. This is when he began to see the need for some critical evaluation. Among other projects, he examined the evidence from 70 trials exploring the benefits of chiropractic therapy in conditions unrelated to the back. He found no evidence to suggest that chiropractors could treat any such conditions.

But what about chiropractic in the context of treating back problems? Manipulating the spine can cure some problems, but results are mixed. To be fair, conventional approaches, such as physiotherapy, also struggle to treat back problems with any consistency. Nevertheless, conventional therapy is still preferable because of the serious dangers associated with chiropractic.

In 2001, a systematic review of five studies revealed that roughly half of all chiropractic patients experience temporary adverse effects, such as pain, numbness, stiffness, dizziness and headaches. These are relatively minor effects, but the frequency is very high, and this has to be weighed against the limited benefit offered by chiropractors.

More worryingly, the hallmark technique of the chiropractor, known as high-velocity, low-amplitude thrust, carries much more significant risks. This involves pushing joints beyond their natural range of motion by applying a short, sharp force. Although this is a safe procedure for most patients, others can suffer dislocations and fractures.
Worse still, manipulation of the neck can damage the vertebral arteries, which supply blood to the brain. So-called vertebral dissection can ultimately cut off the blood supply, which in turn can lead to a stroke and even death. Because there is usually a delay between the vertebral dissection and the blockage of blood to the brain, the link between chiropractic and strokes went unnoticed for many years. Recently, however, it has been possible to identify cases where spinal manipulation has certainly been the cause of vertebral dissection.

Laurie Mathiason was a 20-year-old Canadian waitress who visited a chiropractor 21 times between 1997 and 1998 to relieve her low-back pain. On her penultimate visit she complained of stiffness in her neck. That evening she began dropping plates at the restaurant, so she returned to the chiropractor. As the chiropractor manipulated her neck, Mathiason began to cry, her eyes started to roll, she foamed at the mouth and her body began to convulse. She was rushed to hospital, slipped into a coma and died three days later. At the inquest, the coroner declared: “Laurie died of a ruptured vertebral artery, which occurred in association with a chiropractic manipulation of the neck.”

This case is not unique. In Canada alone there have been several other women who have died after receiving chiropractic therapy, and Edzard Ernst has identified about 700 cases of serious complications among the medical literature. This should be a major concern for health officials, particularly as under-reporting will mean that the actual number of cases is much higher.

If spinal manipulation were a drug with such serious adverse effects and so little demonstrable benefit, then it would almost certainly have been taken off the market.

I personally have seen two strokes (due to verterbral artery occlusions) that I believe were due to chiropractic.

H/T to one of my neurology heroes Steven Novella at Science Based Medicine.

20 July 2009

Space -- the Final Frontier (it really is, you know)

I did see the Apollo 11 Moon Landing. I really did, but I don't remember it. I was a few days shy of 3 years old on July 20, 1969. My parents woke me up and plopped me in front of the TV, but I have no recollection of it. I've seen the pictures -- me sitting in front of a big greenish-looking, very curved TV screen, set in a wooden cabinet.

My equivalent to the moon landing (in my memory) was the first shuttle launch. I watched it on the TV in my parents' bedroom, before school started that day. It was mind-blowing to a science fiction fan like myself -- we were heading out into space in a reusable rocket! I remember thinking "maybe I can take a vacation on the moon, when I'm old, like 40." Unfortunately, I am now over 40, and I can't see touristy-space travel for regular folks during my lifetime. Maybe in TPT's lifetime. I hope she goes to the moon, space stations, Mars, wherever she wants to go. I also remember distinctly when Sally Ride went up in Challenger. At that point, I really wanted to be an astronaut, but knew that would never be (if only because I get seasick on a calm lake, along with specific health reasons). However, my abiding love of science fiction and interest in space has never dimmed.

The closest I've come to space was having the opportunity to watch a real shuttle orbiter launch. One of TheHusband's best friends (and now a good friend of mine) has worked at NASA for years. NASA workers apparently can place their names on a list for shuttle launches -- names are picked in a lottery-like fashion. Well, her name came up in 2000. I was at work in September 2000, when something like the following conversation occurred:

    (ring, ring)
    Neurondoc: Hello?
    TheHusband: Hi. I'll be home late tonight.
    ND: Okay.
    TH: Oh, I talked to C today. She called.
    ND: What's up?
    TH: She wanted to know if we were interested in coming down with her to see a space shuttle launch. I said it seemed interesting but that I'd have to discuss it with you.
    ND (after my jaw hit the desk and my eyes bulged out of their sockets): You didn't say yes?
    TH: No. Why? Do you want to go?
    ND: YES! YES! How come you didn't tell her yes? What if she asks someone else? I want to go. I'm dying to go!
    TH (clearly thinking that his wife has gone off the deep end): Well, how was I supposed to know without talking to you? You always get mad if I make plans without telling you about it first. I'm sure she hasn't asked anyone else yet. She said she'd wait to hear from us first.
    ND (irrational, as any wife is allowed to be): This is different. You should've said yes right away!
    TH: Then why don't you call C and talk directly to her.
    ND: WHAT'S HER NUMBER?
TH gave me C's number and I called her directly. In the intervening 7 minutes since TH had talked to her, she had indeed not asked anyone else, so we got to go to a shuttle launch and sit in the NASA bleachers with the other "VIPs" (not the families of the astronauts -- they are segregated in a separate area, ever since the Challenger disaster). It was amazing. We were as close as one gets to a launch -- 3.2 miles from the launch pad. The viewing site is near the Apollo/Saturn V Center, and the launch was from LC-39A, about 3.2 miles away. If you look on this map, you can see where we sat (next to #1) vs. where the launch pad was (#13).

The launch was STS-97, Endeavour's 15th mission, with planned liftoff at around 10 pm on 11/30/2000. We had to be there a few hours in advance to catch the bus from Kennedy Space Center's main parking area to the viewing site. We had special tickets which allowed us onto the grounds of KSC -- the rabble wasn't allowed in -- and these tickets also got us onto the buses.

It was a night launch, which was good and bad. The launch site was well-lit, as was the area/bleachers where we sat. But we couldn't see the launch area or the shuttle well, as you can see in this picture (the shuttle is the biggest tiny light blob [right-most, bottom]). It was colder than we expected (it's Florida, right?), so we ended up buying one of those mylar space blankets, which kept us warm. The atmosphere in that area was really electric. People were milling around, sitting down, visiting the Apollo/Saturn V Center, taking pictures, chatting.

We climbed up to the second row from the top of the bleachers, figuring to get an unobstructed view (and 4 seats together). We chatted with the people around us. The family sitting behind us was at their 3rd launch -- they still hadn't seen a shuttle actually lift-off, because the previous 2 times they'd come, the launches had been delayed. There was an enormous digital countdown clock (for some reason, I don't have a picture of that), and the actual launch communication between Cape Canaveral and the shuttle itself was broadcast over large speakers. I am not much of a photographer, but I have a little knowledge of film cameras (we bought our first digital camera about 6 months after the launch). I bought high speed film (1000 speed), because I knew a flash would be useless.

Endeavour lifted off on the first try, which was beyond-words-amazing. It actually was bright as day for a few brief seconds...

    Unfortunately, since Launch Day was the 1st day of our vacation, everything after it was a bit of a let-down.

    One funny coincidence -- I was talking to one of my regular patients about 3 months later, and he had been at the same launch, but along the causeway, about 6 (?) miles away.

    22 May 2009

    Other people think Jenny McCarthy is a moron, too!

    I am not the only one! Actually, I knew that, but this post cried out for some hyperbole. Y'all know my feelings about Jenny McCarthy -- I think I've been obvious enough, right? Well, the amazingly erudite, incredibly intelligent, and wonderfully wordy docs over at Science-Based Medicine spend a lot of their energy dealing with Jenny McCarthy and her anti-vaxxer friends. Dr. Jones (not Indiana Jones, you idiot!) published a brilliant post dissecting and repudiating Jenny McCarthy's new video. She also does a great job outlining general concerns about this pervasive, under-the-radar, anti-science attitude which seems to be chic in the upper middle class SAHM set. This video contains the most appalling anti-science "information", really misinformation. Remember, it all spews out of the mouth of a former Playboy model and "actress", who styles herself as more knowledgeable about this issue than doctors.

    I will not foam at the mouth today, but I did have to wash my eyes out with bleach after I watched the video. And yes, I did watch the whole thing.

    16 May 2009

    Jenny McCarthy = RABIES

    I saw two cases of Subacute Sclerosing Panencephalitis, the worst sequela of measles, when I was in medical school. I won't forget either the disease or the two patients who suffered and died of it. I believe strongly in vaccination for the prevention of diseases that are otherwise untreatable and devastating. And the whole anti-vaccination movement literally makes me foam at the mouth ("Neurondoc, do you have rabies?").

    I now have a new hero: The Amateur Scientist. I have a total and unabiding hatred of the crap that Jenny McCarthy spews in her quest to rid the world of vaccinations, all because she believes the disproven (time and again) theory that vaccines (or mercury or thimerasol or too many vaccines in too short a time or ...) cause autism. Because of the anti-vaccination movement, people are dying, formerly sporadic diseases are becoming endemic, and we may be losing our herd immunity. So here is a musical thanks to Jenny from her friends Measles, Mumps and Rubella...



    H/T to Janiece, my current girl crush

    _____________________________________________
    update 5/16, 5:20 pm

    See it's true!
    I am Rabies. Grrrrrrrr!
    Which Horrible Affliction are you?
    A Rum and Monkey disease.

    06 May 2009

    Neurology 101 -- Stroke

    Acute ischemic stroke has been called a "brain attack" and is one of the leading causes of morbidity (illness) and mortality (death) in the US. I am not talking about hemorrhagic or bloody strokes. I am talking about what happens to the brain when the local blood supply is cut off. Before I talk epidemiology or clinical presentation, I will start off with pathogenesis of stroke -- why it happens at the cellular and tissue level.

    Pathogenesis and Pathology of Acute Ischemic Stroke: The process leading from the development of atherosclerosis (deposition of cholesterol and other nasty crap in the arteries) to the occurrence of acute ischemic (non-bloody/non-hemorrhagic) stroke and consequent cell damage is complicated, and many of the intermediary steps are not completely understood. Ischemic stroke is primarily caused by atherosclerosis in large arteries (e.g., carotid, middle cerebral, and basilar arteries) or small arteries (eg, lenticulostriate, basilar penetrating, and medullary arteries), or it may be caused by a thrombus or clot that comes from the left side of the heart and zips up into the cerebral vasculature (cardioembolic). Atherogenesis is the process in which the inside of a blood vessel becomes narrowed by deposition of choleterol, fat, cells, and thrombus material, ultimately to the point of obstruction.

    The earliest atherosclerotic lesion is the fatty streak, which was seen in a large autopsy study of coronary arteries and aortas in patients who died between infancy and age 29. (Stary 1989) In this study, approximately 65% of children ages 12 to 14 years had these lesions. Fatty streaks are visible to the eye as areas of yellowish discoloration of the surface of the intimal (inside) layer of the vessel wall. Under the microscope, the lesions primarily consist of lipid-filled macrophages (foam cells). Macrophages are white blood cells that enter into tissue and ingest foreign material. In this study, 8% of children in late childhood or early adolescence had already developed more advanced, focal lesions. These lesions, which occur almost entirely in branch points of the arterial vessels, are characterized by the addition of massive extra-cellular lipids that displaced normal cells and matrix.

    By the time people are in their 20’s, some atheromatous lesions have evolved into complex fibrous plaques, which consist of a central acellular area of lipid covered by a cap of smooth muscle cells and collagen. Deposition of platelets and fibrin on the surface appears to be the result of injury to the lining cells of the vessel wall (endothelial injury) and clot-dependent fibrotic organization occurs. Over time, these early atherosclerotic lesions progress to clinically relevant and advanced atherosclerosis; risk factors play a role in the development of these more advanced lesions.

    The progression of early atherosclerotic lesions to clinically advanced atherosclerotic lesions occurs with increased frequency in persons with risk factors for atherosclerotic disease (e.g., high blood pressure, high cholesterol, tobacco use). Atherosclerosis is considered to be a response to chronic minimal injury to the endothelial lining of the arterial wall. Interactions among white blood cells (monocytes, platelets, lymphocytes), lipoproteins and smooth muscle cells contribute to and maintain the pathogenic process. Note that monocytes are the circulating blood version of macrophages (in this case, blood cells that eat foreign stuff). Adhesion of circulating monocytes to the internal vessel wall is an early event in the development of atherosclerosis. After adhesion, the monocytes infiltrate between the endothelial cells and enter the subendothelial space and are transformed into lipid-filled macrophages called foam cells.

    The proliferation of smooth muscle cells into the intima and over the layer of foam cells then occurs. Normally, smooth muscle arterial cells are present in the media (middle layer) rather than the intima, and it is the thickening of this layer that makes up a significant amount of the atherosclerotic lesion. Another important step in the formation of a clinically significant atherosclerotic lesion is platelet aggregation and thrombus formation. Platelets are the white blood celss that are responsible for blood clotting. Platelet aggregation is an importnat component of the blood clotting cascade and in the case of atheromatous lesions is thought to occur because of toxins released by macrophages and the ongoing intimal damage. Platelets bind to these areas and release growth factors that further stimulate proliferation of smooth muscle and possibly the formation of the outside capsule of these lesions.

    Repetitive arterial wall injury of this type with thrombus formation is the major mechanism of atherosclerosis. Once blood supply within a vessel has been compromised, damage begins to occur within the neurons and support cells supplied by that artery. The membrane that surrounds the neuron is damaged and becomes leaky, thus allowing for influx of sodium, chloride, water and eventually calcium. Potassium flows out of the cell. Lactic acid and hydrogen further injure the cell, leading eventually to irreversible cellular injury and cell death.

    Not all cells in the region affected by the impaired blood supply die. There are two major zones of injury in the affected regions: the core area of ischemia and the ischemic penumbra. It is within the core area of ischemia that the blood flow is the most impaired (below 25%) and it is here that severe ischemia leads to cell death. However, the penumbra is typically a rim of injured but not dead brain tissue outside of the core ischemic zone. This area is supplied by collateral blood vessels and may remain viable for several hours. However, the collateral circulation is typically unable to supply enough oxygen and nutrients to the injured brain tissue; therefore, unless reperfusion is established these cells eventually die, as well. It is the area of the penumbra that is the primary focus of treatment of acute ischemic strokes. So now you know something about how the cerebral blood vessels become damaged. Now let's talk about what happens to the person.

    Clinical Aspects of Stroke: Stroke is the clinical term for a loss of brain function due to a disturbance in the blood supply in a particular region of the brain. Stroke is subdivided into two types: ischemic (in which the blood supply is interrupted) or hemorrhagic (in which a blood vessel ruptures). The WHO in the 1970s defined stroke as a "neurological deficit of cerebrovascular cause that persists beyond 24 hours or is interrupted by death within 24 hours" in order to differentiate permanent damage from a transient or reversible deficit caused by a transient ischemic attack (TIA). The time frame of 24 hours was chosen somewhat arbitrarily. There are many well-defined risk factors for stroke and include age > 55, hypertension, prior stroke or TIA, diabetes, hyperlipidemia, cigarette smoking, atrial fibrillation, and migraine with aura.

    Signs and symptoms of stroke are dependent on the area of the brain involved. The area of the brain involved in stroke is dependent on the particular blood vessels affected and the type of stroke that occurred (ischemic vs. hemorrhagic). An ischemic stroke involving the anterior circulation (the area of interest in this submission) may result in a variety of neurological deficits. Left (dominant) hemisphere major or branch cortical infarction may lead to the following impairments: aphasia, right hemiparesis (paralysis), right-sided sensory loss, right-sided spatial neglect, right homonymous hemianopia (right half of the visual field is lost), and/or impaired right conjugate gaze. Right (nondominant) hemisphere major or branch cortical infarction may lead to the following impairments: left hemiparesis, left-sided sensory loss, left-sided spatial neglect, left homonymous hemianopia, and/or impaired left conjugate gaze.

    Stroke is diagnosed via history, physical and neurological examination, and neuroimaging; it is most commonly diagnosed in an emergency room setting. It is highly important to differentiate between ischemic and hemorrhagic stroke as the management of these conditions is very different. A recent study comparing the effectiveness of MRI and CT for the diagnosis of acute stroke in a suburban hospital found MRI to be more effective in identifying acute stroke of all types.

    Treatment of Acute Ischemic Stroke: Approved treatment for acute ischemic stroke is limited to a single therapy – intravenous recombinant tissue plasminogen activator, or IV-rtPA. Thrombectomy via the clot retrieval devices can be used in the setting acute ischemic stroke, these devices have not been approved or cleared for the treatment of stroke. The significant limiting factor for both of these treatments is the time from known onset to presentation to the ER. IV-rtPA must be administered within 3 hours of onset of stroke symptoms and the neurothrombectomy must occur within 8 hours. Only preventative and rehabilitative therapies exist beyond these two therapeutic options.

    Epidemiology of Stroke (primarily from the Heart Disease and Stroke Statistics—2008 Update: A Report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee): Stroke is one of the most common disorders affecting the American population. The incidence of new or recurrent strokes among Americans is about 700,000, and 87% of these are ischemic strokes. About 500,000 of these are new strokes, and 200,000 are recurrent attacks. At younger ages, the stroke incidence rates in men are greater than in women but not at older ages. The male/female incidence was 1.25 in those 55 to 64 years of age, 1.50 in people 65 to 74 years of age, 1.07 in those 75 to 84 years of age, and 0.76 in those 85 years or greater. African-Americans are at a greater risk of stroke than whites. The age-adjusted stroke incidence rates in those 45 to 84 years of age are 6.6 per 1000 population in black males, 3.6 in white males, 4.9 in black females, and 2.3 in white females. Prevalence of stroke varies according to race: in 2005 it was 2.5% among whites, 3.2% among African-Americans, 2.4% among Asians and 5.1% among Native Americans.

    Mortality due to stroke is an important consideration. Stroke accounted for about 1 of every 16 deaths in the United States in 2004. About 50% of stroke deaths in 2003 occurred out of hospital. Stroke total-mention mortality in 2002 was about 273,000 and ranks 3rd among all causes of death (behind heart disease and cancer). According to the ARIC study (NHLBI), 8 to 12% of ischemic strokes and 37 to 38% of hemorrhagic strokes result in death within 30 days, among people between the ages of 45 and 64, although the total rates are probably higher than these. An epidemiological study of stroke in Europe revealed an overall mortality rate (hemorrhagic and ischemic stroke) of 20% at 28 days. (Bejot 2007) A study of patients aged 65 recruited from a random sample of HCFA Medicare Part B eligibility lists showed that the 1-month case fatality was 12.6% for all strokes (8.1% ischemic and 44.6% hemorrhagic). The 2004 overall death rate for stroke was 50.0 (48.1 for white males, 73.9 for black males, 47.4 for white females, and 64.9 for black females). In 2002, the mean age at stroke death was 79.6 years. Males had a younger mean age at stroke death than females, and blacks, American Indians, and Asians had younger mean ages at death than whites.


    Stroke is a leading cause of serious, long-term disability in the United States according to a survey of the US Bureau of the Census. In 1999, more than 1,100,000 American adults had some level limitations in function and/or activities of daily living, resulting from stroke. The length of time to recover from a stroke depends on its severity. 50% to 70% of stroke survivors regain functional independence; however, 15% to 30% are permanently disabled, and 20% require institutional care at 3 months after onset. In a study of ischemic stroke survivors who were at least 65 years of age, these disabilities were observed 6 months post-stroke:
    • 50% had some hemiparesis;
    • 30% were unable to walk without some assistance;
    • 26% were dependent in activities of daily living;
    • 19% had aphasia (inability or difficulty in expressing or comprehending language);
    More tomorrow, maybe...

    28 April 2009

    Seattle and the Bow Ties

    So I have been in Seattle since Saturday afternoon. I am here for the annual meeting of the American Academy of Neurology. I have been a member of the AAN for 15 years and have been to 6 or 7 annual meetings. I have frequently referred to the AAN annual meeting as one of the largest collection of old white guys wearing bow ties, because, well, there are lots of old white guys wearing bow ties here.

    I have some random thoughts about this year's meeting:
    • This meeting seems to be much less well-attended than the last few I went to -- less people around, little crowds, no pushing or being pushed.
    • Neurobowl (neurology trivia contest) is still fun.
    • There are a lot fewer freebies from the drug and device companies, which is fine with me.
    • Fewer Europeans seem to be here this year than last year, but that may be a function of the West Coast location.
    • The "free" seminars and lectures are the usual combination of completely obscure ("A Tat-Immune Complex Binds the NMDA Receptor, Preventing Receptor Activation and Excitotoxicity"), unrelated to anything I might ever do or see ("Predictive Value of Brainstem Auditory Evoked Potentials (BAEPs) in Decreasing Post Operative Neurological Deficit During Expanded Endonasal Approach (EEA) to Skull Base Surgeries"), interesting ("The Transition of REM Sleep Behavior Disorder to Neurodegenerative Disease") and something that may seriously affect what I do on a daily basis ("Improving Reliability of Stroke Disability Assessment in Clinical Trials and Clinical Practice: The Focused Assessment for the Modified Rankin Scale").
    • Neurology of Sleep was (unfortunately) well-named. It was really hard to stay awake.
    • I chatted with the former chairman of the Dept of Neurology at my medical school. He was very supportive of me when I was a med student, and I hadn't seen him in years. He didn't remember seeing me at my Boards.
    • It's much more fun to come to these meetings with coworkers.
    • KOLs can be pompous and annoying, but often they have very interesting theories, ideas, projects, and clinical trials.
    I have one more seminar this afternoon and the Plenary Session tomorrow morning, and then I will be having lunch with a former coworker tomorrow. Who knows what kind of trouble I can get into between now and noon tomorrow? Then it is off to Vancouver with TheHusband for a couple of days (minus ThePinkThing, who will be hanging at home with her grandmother).

    16 April 2009

    Neuroloy 101 -- Huntington's Disease (part 1)

    Let’s talk “diagnose and adios” today. I am going to tell you about one of the biggies, one of the really bad neurologic diseases, up there in the top 10, maybe even the top 5, of “neurologic diseases that you don’t want to get”. But in a weird way, it is near and dear to my heart (no, I don’t have it, nor am I likely to develop it), and I’ll get to why in a bit. I am talking about Huntington’s disease (or Huntington’s chorea, as it was once called). Huntington’s disease is a classic progressive, degenerative neurologic disease that neurologists really can’t treat. Clinical signs and symptoms include chorea, cognitive impairments and psychiatric problems.

    It is a hereditary disease that is transmitted from one parent in an autosomal dominant pattern. For those of you who took high school biology, but don’t remember it, autosomal inheritance occurs when the gene carrying the mutation is located on an “autosome” (non-sex chromosome). If something is inherited in an dominant pattern that means that only one gene is necessary for the disease to occur. And because only one gene is necessary for development of the disease, children of an affected parent have a 50/50 chance of having the disease. I am going to leave this genetics discussion simple and not get into variable expression or reduced penetrance. Suffice it to say that if one of your parents has Huntington’s disease (HD), you have a 50% chance of getting it. But it is a little more complicated than that, actually.


    It is the genetics of Huntington’s disease that is so fascinating. The Huntingtin gene, located on the short arm of chromosome 4, was identified in 1993 and was the first non-sex-linked dominant disease gene to be documented. It is one of the trinucleotide repeat disorders. These are genetic disorders in which one DNA triplet (trinucleotide) in the gene sequence is repeated multiple times. It is this repetition, at least in the case of HD, that causes the clinical symptoms. The three DNA bases—cytosine-adenine-guanine (CAG)—repeated multiple times (i.e. ...CAGCAGCAG...) in a protein-coding portion of the gene (the protein is, not surprisingly, called huntingtin). CAG is the genetic code for the amino acid glutamine, so a series of CAGs results in a chain of glutamine known as a polyglutamine or polyQ tract.


    Normal people do have CAG repeats in that region of chromosome 4; normal is considered less than 29 glutamine repeats. If a person has 29 – 34 CAG repeats, the resulting huntingtin protein will function normally, but the next generation is at risk. The gray zone is 35-39 CAG repeats, which will cause the disease in some patients but not others (the reduced penetrance I mentioned earlier). If the patient has 40 or more repeats, they will develop HD. Trinucelotide repeat disorders are frequently associated with genetic anticipation, in which successive generations have increasing numbers of CAG repeats and earlier/more severe disease expression.

    There is genetic testing available that calculates the number of trinucleotide repeats. Most people at risk of developing HD do not actually take the test prior to developing symptoms, primarily because there is no treatment. Prior to ordering the test, significant counseling is recommended. In utero genetic screening is also available.


    The altered or mutant huntingtin increases the decay rate of medium spiny neurons, which affects specific regions of the brain depending on the amounts of these neurons. The areas of the brain most affected, as seen in histopathological examinations are the caudate nucleus and putamen. These comprise the striatum. Other areas that are affected include the substantia nigra, parts of the cerebral cortex, hippocampus, angular gyrus, purkinje cells in the cerebellum, parts of the hypothalamus and thalamus. It is the striatal degeneration that causes the most prominent symptoms of HD.



    Huntington's brain ------------- Normal brain

    The symptoms of HD most commonly appear between the ages of 35 and 44, typically after the patient has had children. Presentation may occur before age 20, which is called the akinetic-rigid or Westphal variant. The most common symptom seen in HD patients is chorea. These are jerky, random, and uncontrollable movements that are almost dance-like (hence the name chorea – from choreos – dance in Greek). Other motor symptoms are rigidity and dystonia (sustained muscle contractions causing twisting movements or abnormal posture), which typically become more prominent than the chorea as the disease progresses. Motor impersistence (difficulty maintaining a specific motor task) is another common sign of HD. One way to assess this is to have the patient stick his tongue out. He will not be able to hold it out for more than a few seconds. It will go back in, then out, etc… Motor control is severely affected as the disease progresses, causing instability, inability to walk, difficulty chewing swallowing and talking.

    Cognitive dysfunction is also present, commonly prior to development of the motor symptoms. Progressive cognitive decline will almost inevitably occur in these patients, with memory difficulties (initially short-term, then long-term as well). The cognitive decline eventually leads to dementia in most patients. It is a subcortical dementia, with prominent personality changes and attentional difficulties, rather than a cortical dementia, as seen in Alzheimer’s disease. Psychiatric problems are also not infrequently seen in these patients – depression, anxiety, aggression, even psychosis. The psychiatric manifestations can severely affect the patient’s ability to function and may be a trigger for institutionalization.


    There is no cure and no effective treatment for the disease. Tetrabenazine was approved for the treatment of chorea in HD patients, the only drug approved for this particular use. Other drugs used in the reduction of HD chorea are neuroleptics (antipsychotic drugs) and benzodiazepines (Valium and its cousins). For the most part, medications are used to reduce the symptoms and are only semi-effective. Anti-parkinsonian drugs can sometimes be used for rigidity. Anti-depressants may help mood disorders. Speech therapy to help with the dysphagia is crucial for the patients to maintain their weight. Prognosis for these patients basically sucks. Life expectancy ranges from 10-30 years from diagnosis, and the disease is inexorably progressive. Patients die of associated complications (pneumonia, aspiration, injury, choking). Suicide is not uncommon (~7%).


    Tomorrow, I will tell you why this disease is important to me…

    27 March 2009

    Big!

    Just a quickie post to show a totally cool picture that warms my science-y heart. Here is a picture of the ash cloud from Mt. Redoubt taken from a geostationary satellite that is over Asia. That is freaking enormous!


    Photo courtesy of the National Weather Service, processed by the Cooperative Institute for Meteorological Satellite Studies at the University of Wisconsin-Madison. Picture Date: March 26, 2009 17:30:00 UTC. Downloaded from http://www.avo.alaska.edu/image.php?id=17104

    Bite me, Bobby Jindal. (I know, I know, that's a gratuitous snark, but I couldn't help myself.)